Mylan to buy Agila Specialties from Strides for $1.6bn

Thu, Feb 28, 2013 at 04:26

Generic drugmaker Mylan Inc said it would buy Agila Specialties from Strides Arcolab Ltd for USD 1.6 billion to expand its injectable drugs business.

Like this story, share it with millions of investors on M3

Mylan to buy Agila Specialties from Strides for $1.6bn

Generic drugmaker Mylan Inc said it would buy Agila Specialties from Strides Arcolab Ltd for USD 1.6 billion to expand its injectable drugs business.

Like this story, share it with millions of investors on M3

Mylan to buy Agila Specialties from Strides for $1.6bn

Generic drugmaker Mylan Inc said it would buy Agila Specialties from Strides Arcolab Ltd for USD 1.6 billion to expand its injectable drugs business.

  .   Share  .  Email  .  Print  .  A+A-

To download current article in Word format, click here.

Generic drugmaker Mylan Inc said it would buy Agila Specialties from Strides Arcolab Ltd for USD 1.6 billion to expand its injectable drugs business.

Mylan, one of the world's largest generic drugmakers with more than 1,100 products, said the acquisition is expected to immediately add to Mylan's adjusted diluted earnings per share following closing.

Mylan said the deal was unanimously approved by its board.

To download current article in Word format, click here.

highlights

• Economic slowdown a wake-up call for stepping up reforms
• Future shift in RBI policy stance would be desirable.
• Tight RBI policy led to sharper-than-expected slowdown
• April-December data shows 5.3% fiscal gap aim 'achievable'.

more »

flashes

• Budget a significant event given current BoP crisis: Nirmal Jain
• Freeze in government spending to impact economic growth: Vetri Subramaniam
• FY14 Budget not a make or break event for economy: Vetri Subramaniam
• Budget unlikely to be populist but may be driven by politics:Vetri Subramaniam

more »

InterpretationS

• Railway minister has done a commendable job in meeting competing demands of improving services and controlling expenditure: PM
• It is a reformist and forward- looking Budget: PM
• If you look at the overall Budget, it was relatively muted and there was nothing exciting and no steps were taken, which would make the market happy: ICICI Direct
• There is no major capex from the civil construction on the freight corridor, though some investments are coming on the metro side: KEC International

more »

SECTOR IMPACT

Select Sector to see impact

EXPECTATIONS

expectation on: Policy

Latha Venkatesh

Banking editor | CNBC-TV18

expectation on: Policy

Kiran Mazumdar Shaw

CMD | Biocon

expectation on: People

Saumitra Chaudhuri

Member | PMEAC

expectation on: Markets

Tirthankar Patnaik

NULL | Religare Cap Markets

expectation on: Markets

Ajay Srivastava

CEO | Dimensions Consulting

Anda sedang membaca artikel tentang

Mylan to buy Agila Specialties from Strides for $1.6bn

Dengan url

http://sehatkafein.blogspot.com/2013/02/mylan-to-buy-agila-specialties-from.html?m=0

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Mylan to buy Agila Specialties from Strides for $1.6bn

namun jangan lupa untuk meletakkan link

Mylan to buy Agila Specialties from Strides for $1.6bn

sebagai sumbernya